In-hospital case fatality rates for acute myocardial infarction in Romania

CMAJ. Canadian Medical Association Journal

Volumn 180, Issue 12, 2009, Pages 1207-1213

  Tatu Chitoiu, Gabriel ^a   Cinteza, Mircea ^b   Dorobantu, Maria ^a   Udeanu, Mariana ^b,g   Manfrini, Olivia ^g   Pizzi, Carmine ^g   Vintila, Marius ^c   Ionescu, Dominic D ^d   Craiu, Elvira ^e   Burghina, Daniel ^f   Bugiardini, Raffaele ^g  

^a Floreasca Emergency Hospital   (Romania)

^b Emergency University Hospital   (Romania)

^c Pantelimon Hospital   (Romania)

^d Center of Cardiology   (Romania)

^e Pediatric Department   (Romania)

^f Department of Internal Medicine   (Romania)

^g UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD CLOT LYSIS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CIGARETTE SMOKING; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; ROMANIA; SEX DIFFERENCE; ST SEGMENT ELEVATION; AGED; CLINICAL PRACTICE; CLINICAL TRIAL; FIBRINOLYTIC THERAPY; HEALTH CARE QUALITY; HEART INFARCTION; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; REGISTER; TRANSLUMINAL CORONARY ANGIOPLASTY; UTILIZATION REVIEW;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; QUALITY OF HEALTH CARE; REGISTRIES; ROMANIA; THROMBOLYTIC THERAPY;

EID: 67649194625     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.081227     Document Type: Article

References (29)

1. World Health Organization, Regional Office for Europe. The European health report 2002. Copenhagen (Denmark): The Organization; 2002. p. 7-45.
2. Tunstall-Pedoe H, Vanuzzo D, Hobbs M, et al. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA project populations. Lancet 2000;355:688-700.
3. U.S. government assistance to Eastern Europe under the Support for East European Democracy (SEED) Act. Washington (DC): US Department of State, Bureau of European and Eurasian Affairs; 2004. p. 68-113.
4. Gurjeva OS, Bukhman G, Murphy S, et al. Treatment and outcomes of eastern Europeans with coronary syndromes in OPUS-TIMI 16. Int J Cardiol 2005;100:101-7.
5. Kramer JM, Newby LK, Chang WC, et al. International variation in the use of evidence-based medicines for acute coronary syndromes. Eur Heart J 2003;24:2133-41.
6. Mega JL, Morrow DA, Östör E, et al. Outcomes and optimal antithrombotic therapy in women undergoing fibrinolysis for ST-elevation myocardial infarction. Circulation 2007;115:2822-8.
7. National Institute of Statistics. Romanian statistical yearbook. Bucharest (Romania): The Institute; 2006. p. 73-9.
8. Thygesen K, Alpert JS, White HD, et al.; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, et al. Universal definition of myocardial infarction. Circulation 2007;116:2634-53.
9. Vaccarino V, Parsons L, Every NR, et al. Sex-based differences in early mortality after myocardial infarction. N Engl J Med 1999;341:217-25.
10. Hochman JS, Lamas GA, Buller CE, et al. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med 2006;355:2395-407.
11. James PA, Li P, Ward MM. Myocardial infarction mortality in rural and urban hospitals: rethinking measures of quality of care. Ann Fam Med 2007;5:105-11.
12. Rosengren A, Wallentin L, K Gitt A, et al. Sex, age, and clinical presentation of acute coronary syndromes. Eur Heart J 2004;25:663-70.
13. Mandelzweig L, Battler A, Boyko V, et al. The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J 2006;27:2285-93.
14. Rogers WJ, Frederick PD, Stoehr E, et al. Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006. Am Heart J 2008;156:1026-34.
15. Gibson CM, Pride YB, Frederick PD, et al. Trends in reperfusion strategies, doorto-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006. Am Heart J 2008;156:1035-44.
16. Bara AC, van den Heuvel WJ, Maarse JA. Reforms of health care system in Romania. Croat Med J 2002;43:446-52.
17. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-22.
18. Boersma E, Maas AC, Deckers JW, et al. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996;348:771-5.
19. Morrison LJ, Verbeek PR, McDonald AC, et al. Mortality and prehospital thrombolysis for acute myocardial infarction: a meta-analysis. JAMA 2000;283:2686-92.
20. Steg PG, Bonnefoy E, Chabaud S, et al.; Comparison of Angioplasty and Prehospital Thrombolysis In Acute Myocardial Infarction (CAPTIM) Investigators. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial. Circulation 2003;108:2851-6.
21. Antman EM, Hand M, Armstrong PW, et al. 2007 focused update of the ACC/AHA 2004 Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2008;117:296-329.
22. Kober L, Torp-Pedersen C, Ottesen M, et al. Influence of gender on short- and longterm mortality after acute myocardial infarction. Am J Cardiol 1996;77:1052-6.
23. Yarzebski J, Col N, Pagely P, et al. Gender differences and factors associated with the receipt of thrombolytic therapy in patients with acute myocardial infarction: a community-wide perspective. Am Heart J 1996;131:43-50.
24. Kudenchuk PJ, Maynard C, Martin JS, et al. Comparison of presentation, treatment, and outcome of acute myocardial infarction in men versus women. Am J Cardiol 1996;78:9-14.
25. Maynard C, Althouse R, Cerqueira M, et al. Underutilization of thrombolytic therapy in eligible women with acute myocardial infarction. Am J Cardiol 1991;68:529-30.
26. McLaughlin TJ, Soumerai SB, Willison DJ, et al. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and elderly. Arch Intern Med 1996;156:799-805.
27. Gurwitz JH, Gore JM, Goldberg RJ, et al. Recent age-related trends in the use of thrombolytic therapy in patients who have had acute myocardial infarction: National Registry of Myocardial Infarction. Ann Intern Med 1996;124:283-91.
28. Vaccarino V, Rathore SS, Wenger NK, et al. Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med 2005;353:671-82.
29. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Unstable Angina). Circulation 2000;102:1193-209.